CoChat

Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective

Open access
Tse, Lurdes, Barr, Alasdair, Scarapicchia, Vanessa, Vila-Rodriguez, Fidel · 2015 · Current Neuropharmacology

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Abstract

Neuroleptic malignant syndrome (NMS) is a rare but potentially life-threatening side-effect that can occur in response to treatment with antipsychotic drugs. Symptoms commonly include hyperpyrexia, muscle rigidity, autonomic dysfunction and altered mental status. In the current review we provide an overview on past and current developments in understanding the causes and treatment of NMS. Studies on the epidemiological incidence of NMS are evaluated, and we provide new data from the Canada Vigilance Adverse Reaction Online database to elaborate on drug-specific and antipsychotic drug polypharmacy instances of NMS reported between 1965 and 2012. Established risk factors are summarized with an emphasis on pharmacological and environmental causes. Leading theories about the etiopathology of NMS are discussed, including the potential contribution of the impact of dopamine receptor blockade and musculoskeletal fiber toxicity. A clinical perspective is provided whereby the clinical presentation and phenomenology of NMS is detailed, while the diagnosis of NMS and its differential is expounded. Current therapeutic strategies are outlined and the role for both pharmacological and non-pharmacological treatment strategies in alleviating the symptoms of NMS are discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/1570159x13999150424113345

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. (1) Number of cases of NMS associated with atypical antipsychotics reported in the Canada Vigilance Adverse Reaction Online Database.
Fig. (1) Number of cases of NMS associated with atypical antipsychotics reported in the Canada Vigilance Adverse Reaction Online Database.CC BY-NC · PubMed Central
Fig. (2) Number of cases of NMS associated with typical antipsychotics reported in the Canada Vigilance Adverse Reaction Online Database.
Fig. (2) Number of cases of NMS associated with typical antipsychotics reported in the Canada Vigilance Adverse Reaction Online Database.CC BY-NC · PubMed Central
Fig. (3) Etiopathogenesis of Neuroleptic Malignant Syndrome and its clinical manifestations. Khaki-coloured boxes describe risk factors associated with NMS, green ovals describe etiopathogenic mechanisms that lead to pathophysiological changes in orange polygons that result in clinical symptomatology in red stars. Abbreviations: ANS, autonomic nervous system; BP, blood pressure; Dp, dopamine; HR, heart rate; RR, respiration rate.
Fig. (3) Etiopathogenesis of Neuroleptic Malignant Syndrome and its clinical manifestations. Khaki-coloured boxes describe risk factors associated with NMS, green ovals describe etiopathogenic mechanisms that lead to pathophysiological changes in orange polygons that result in clinical symptomatology in red stars. Abbreviations: ANS, autonomic nervous system; BP, blood pressure; Dp, dopamine; HR, heart rate; RR, respiration rate.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 73 references

Cited by

See all 214

Metadata

Authors
Tse, L., Barr, A., Scarapicchia, V., & Vila-Rodriguez, F.
Affiliations
  • University of British Columbia Hospital (CA)
  • University of British Columbia (CA)
Venue
Current Neuropharmacology
Published
2015-07-14
Volume
13
Issue
3
Pages
395-406
ISSN
1570-159X (ISSN-L)
OpenAlex
W2332600596
Cited by
179
References
73
Citations by year
2026: 7 · 2025: 18 · 2024: 25 · 2023: 26 · 2022: 15 · 2021: 27 · 2020: 11 · 2019: 16 · 2018: 19 · 2017: 4 · 2016: 10 · 2015: 1
FWCI
9.19
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Current Neuropharmacology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords
neuroleptic malignant syndrome, antipsychotic adverse effects, hyperpyrexia, muscle rigidity, autonomic dysfunction, altered mental status, adverse drug reaction reporting, risk factors, dopamine receptor blockade, etiopathogenesis, diagnosis, differential diagnosis, treatment options, polypharmacy
MeSH terms
Animals, Diagnosis, Differential, Humans, Muscle Rigidity, Neuroleptic Malignant Syndrome, Risk Factors, Antipsychotic Agents, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective. https://app.cochat.ai/papers/10.2174/1570159x13999150424113345
The paper
Tse, L., Barr, A., Scarapicchia, V., & Vila-Rodriguez, F. (2015). Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective. Current Neuropharmacology. https://doi.org/10.2174/1570159x13999150424113345

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.